CureVac N.V.
CVAC · NASDAQ
11/24/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.33 | -0.05 | 0.05 |
| FCF Yield | 0.00% | -4.20% | -7.27% | -9.36% |
| EV / EBITDA | 0.00 | -12.38 | -3.75 | -8.48 |
| Quality | ||||
| ROIC | 0.00% | -9.80% | -7.98% | -5.05% |
| Gross Margin | 95.76% | -77.75% | 2.02% | 89.73% |
| Cash Conversion Ratio | 0.70 | 0.80 | 1.73 | 0.96 |
| Growth | ||||
| Revenue 3-Year CAGR | 128.34% | 138.55% | 118.54% | 99.48% |
| Free Cash Flow Growth | 0.00% | -4.14% | 39.41% | -119.71% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 6.49 | 8.58 | 12.69 |
| Interest Coverage | 53.26 | -109.28 | -164.35 | 68.80 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 4.09 | 1.62 | 2.75 |
| Cash Conversion Cycle | 0.00 | 270.46 | 170.75 | -808.66 |